Immunization should be performed only by intramuscular injection.
In infants, the recommended injection site is the anterolateral thigh. In persons older than 1 year, the recommended injection site is the anterolateral part of the thigh or the deltoid muscle.
Nimenrix® vaccine is indicated for active immunization of individuals 6 weeks of age and older against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135, and Y.
Hypersensitivity to active substances or any excipients included in the vaccine
Side effects:
Rarely can be observed: